KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) FCF Margin (2016 - 2025)

Teladoc Health's FCF Margin history spans 12 years, with the latest figure at 13.25% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1680.0% year-over-year to 13.25%; the TTM value through Dec 2025 reached 11.28%, up 426.0%, while the annual FY2025 figure was 11.28%, 426.0% up from the prior year.
  • FCF Margin for Q4 2025 was 13.25% at Teladoc Health, down from 24.07% in the prior quarter.
  • Across five years, FCF Margin topped out at 25.87% in Q3 2024 and bottomed at 6.31% in Q1 2022.
  • The 5-year median for FCF Margin is 5.31% (2022), against an average of 6.76%.
  • The largest annual shift saw FCF Margin skyrocketed 3631bps in 2021 before it tumbled -1792bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 6.03% in 2021, then tumbled by -54bps to 2.8% in 2022, then surged by 414bps to 14.38% in 2023, then crashed by -125bps to 3.54% in 2024, then skyrocketed by 474bps to 13.25% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's FCF Margin are 13.25% (Q4 2025), 24.07% (Q3 2025), and 9.89% (Q2 2025).